Daewoong Pharmaceutical, along with AstraZeneca Korea, is pushing to target the Asian market for Crezet, a hyperlipidemia treatment.

Daewoong Pharmaceutical signed a cooperative contract with AstraZeneca Korea on the 27th and agreed to push for Crezet exports to Indonesia, Thailand, the Philippines, and Malaysia. Crezet is a composite of Rosuvastatin Calcium and Ezetimbe.

The signing ceremony was held at AstraZeneca headquarters in Gangnam-gu, Seoul. Jeon Seung-ho, CEO of Daewoong Pharmaceutical, Park Sung-soo, vice president of Daewoong Pharmaceutical, and Kim Sang-pyo, CEO of AstraZeneca Korea, Jo Feng, president of AstraZeneca Asia, and presidents of Indonesia, Thailand, Philippines, a